Enhanced tumor killing by Apo2L/TRAIL and CPT-11 co-treatment is associated with p21 cleavage and differential regulation of Apo2L/TRAIL ligand and its receptors.
about
Role of activating transcription factor 3 (ATF3) in endoplasmic reticulum (ER) stress-induced sensitization of p53-deficient human colon cancer cells to tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis throughMolecular targets of TRAIL-sensitizing agents in colorectal cancerLocalization of TRAIL/TRAILR in fetal pancreasTumor necrosis factor alpha sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-kappaB.Multi-layered nanoparticles for combination gene and drug delivery to tumors.Combination treatment with TRA-8 anti death receptor 5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancerTRAIL receptor-targeted therapy.TRAIL-receptor antibodies as a potential cancer treatment.Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11.To kill a tumor cell: the potential of proapoptotic receptor agonistsKey role of ATF3 in p53-dependent DR5 induction upon DNA damage of human colon cancer cells.The proteasome inhibitor bortezomib promotes mitochondrial injury and apoptosis induced by the small molecule Bcl-2 inhibitor HA14-1 in multiple myeloma cells.
P2860
Q24299363-D8FC2036-491E-44A4-A29D-DFF21F312674Q26822382-3EC68758-83E9-401F-88D9-D2A9B19B4268Q30881749-3B6D24DC-65AA-4E1A-B2B2-645B038F37E6Q33205160-7CEF8015-CF2C-4E9D-A4BF-0642C3C1F182Q34135640-EFAA0F93-29A4-4683-B5A7-1CE73DF9F755Q34610496-EC761770-8BC7-400A-89ED-56E0CDB06CB8Q36572530-1AD20FC1-AC35-4F57-B599-4B75DC63F387Q36895805-2E940873-099F-40B3-A27B-C32DF1FA2DF1Q37178718-DCEEDED8-714E-42AA-8803-AC9AFCAAAFA1Q37181734-0941FE0C-22CD-4B4C-9AF9-286E7F1B777FQ39472164-5BC69E7F-970A-40E8-9D85-606D96AA921EQ44598665-369AC375-2F47-4A5F-879D-FE14EF6244D3
P2860
Enhanced tumor killing by Apo2L/TRAIL and CPT-11 co-treatment is associated with p21 cleavage and differential regulation of Apo2L/TRAIL ligand and its receptors.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Enhanced tumor killing by Apo2 ...... RAIL ligand and its receptors.
@en
type
label
Enhanced tumor killing by Apo2 ...... RAIL ligand and its receptors.
@en
prefLabel
Enhanced tumor killing by Apo2 ...... RAIL ligand and its receptors.
@en
P2093
P2860
P356
P1433
P1476
Enhanced tumor killing by Apo2 ...... RAIL ligand and its receptors.
@en
P2093
Dominick Sinicropi
Enrique Escandón
Hong Xiang
Judith A Fox
Kelly Dupree
Klara Totpal
Mina Aikawa
P2860
P2888
P304
P356
10.1038/SJ.ONC.1205449
P407
P577
2002-05-01T00:00:00Z
P5875
P6179
1035717170